Rapid Removal of gDNA from RNA Samples
Porvair Sciences has launched Chromatrap® gDNA Removal Columns that quickly remove unwanted genomic DNA from RNA samples.
ERS Genomics and genOway Enter CRISPR/Cas9 Agreement
ERS Genomics Limited and genOway have announced a non-exclusive license agreement granting genOway past and future access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay
10x Genomics has announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay. The offering gives researchers access to the whole transcriptome across their entire tissue, enabling true unbiased discovery in FFPE samples for the first time.
Kits by Izon Science Standardize Extracellular Vesicle Concentration and EV-RNA Extraction
Izon Science Ltd, the manufacturer of nano-biological separation and characterization tools, announced today the release of two new kits: the qEV Concentration Kit for the isolation and concentration of extracellular vesicles (EVs), and the qEV RNA Extraction Kit, which enables the extraction of RNA from EVs.
Foresight Diagnostics Completes Series A Financing To Accelerate Minimal Residual Disease Technology
Foresight Diagnostics has announced the close of its $12.5M Series A financing to commercialize the minimal residual disease (MRD) detection assay.
Japanese Patent Office Upholds Key Charpentier/Doudna CRISPR Patent
ERS Genomics Limited has announced that the Japanese Patent Office (JPO) has rejected arguments filed in opposition to the second Japanese patent. In addition, the JPO has allowed a third CVC patent which covers a chimeric version of the Cas9 protein.